Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
HLA ; 2018 Apr 23.
Article in English | MEDLINE | ID: mdl-29687612

ABSTRACT

The Babraham pig is a highly inbred breed first developed in the United Kingdom approximately 50 years ago. Previous reports indicate a very high degree of homozygosity across the genome, including the major histocompatibility complex (MHC) region, but confirmation of homozygosity at the specific MHC loci was lacking. Using both direct sequencing and PCR-based sequence-specific typing, we confirm that Babraham pigs are essentially homozygous at their MHC loci and formalise their MHC haplotype as Hp-55.6. This enhances the utility of the Babraham pig as a useful biomedical model for studies in which controlling for genetic variation is important.

2.
Transbound Emerg Dis ; 63 Suppl 1: 14-29, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320163

ABSTRACT

We assessed knowledge gaps in foot-and-mouth disease (FMD) research, and in this study, we consider (i) epidemiology, (ii) wildlife and (iii) economics. The study took the form of a literature review (2011-2015) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD research. During 2011-2015, modelling studies were dominant in the broad field of epidemiology; however, continued efforts are required to develop robust models for use during outbreaks in FMD-free countries, linking epidemiologic and economics models. More guidance is needed for both the evaluation and the setting of targets for vaccine coverage, population immunity and vaccine field efficacy. Similarly, methods for seroprevalence studies need to be improved to obtain more meaningful outputs that allow comparison across studies. To inform control programmes in endemic countries, field trials assessing the effectiveness of vaccination in extensive smallholder systems should be performed to determine whether FMD can be controlled with quality vaccines in settings where implementing effective biosecurity is challenging. Studies need to go beyond measuring only vaccine effects and should extend our knowledge of the impact of FMD and increase our understanding of how to maximize farmer participation in disease control. Where wildlife reservoirs of virus exist, particularly African Buffalo, we need to better understand when and under what circumstances transmission to domestic animals occurs in order to manage this risk appropriately, considering the impact of control measures on livelihoods and wildlife. For settings where FMD eradication is unfeasible, further ground testing of commodity-based trade is recommended. A thorough review of global FMD control programmes, covering successes and failures, would be extremely valuable and could be used to guide other control programmes.


Subject(s)
Animals, Wild , Foot-and-Mouth Disease , Animals , Foot-and-Mouth Disease/economics , Foot-and-Mouth Disease/epidemiology , Foot-and-Mouth Disease/prevention & control
3.
Transbound Emerg Dis ; 63 Suppl 1: 3-13, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320162

ABSTRACT

The Global Foot-and-mouth disease (FMD) Research Alliance periodically reviews the state of FMD research to assess progress and to identify new priorities. In this supplement we provide an update of global FMD research, comprising (i) this overview paper, which includes background information with key findings, and papers covering (ii) epidemiology, wildlife and economics, (iii) vaccines, (iv) diagnostics, (v) biotherapeutics and disinfectants, (vi) immunology and (vii) pathogenesis and molecular biology. FMD research publications were reviewed (2011-2015) and activity updates were obtained from 33 FMD research institutes from around the world. Although a continual threat, FMD has been effectively controlled in much of the world using existing tools. However, control remains a challenge in most developing countries, where little has been done to understand the ongoing burden of FMD. More research is needed to support control in endemically infected countries, particularly robust field studies. Traditional FMD vaccines have several limitations including short duration and spectrum of protection, cold chain requirements, and the costs and biosecurity risks associated with vaccine production. Significant progress has been made in the development of novel vaccine candidates, particularly in the use of recombinant vaccines and virus-like particles as an alternative to traditional inactivated whole virus vaccines. Continued investment is needed to turn these developments into improved vaccines produced at scale. Increased knowledge of cellular and mucosal immunity would benefit vaccine development, as would further advances in our ability to enhance vaccine capsid stability. Developments in molecular biology and phylogenetics underlie many of the recent advances in FMD research, including improved vaccines and diagnostics, and improved understanding of FMD epidemiology. Tools for genetic analyses continue to become both more powerful and more affordable enabling them to be used to address an ever-expanding range of questions. This rapidly advancing field potentiates many areas of FMD research and should be prioritized.


Subject(s)
Foot-and-Mouth Disease , Animals , Foot-and-Mouth Disease/diagnosis , Foot-and-Mouth Disease/epidemiology , Foot-and-Mouth Disease/therapy
4.
Transbound Emerg Dis ; 63 Suppl 1: 49-55, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320166

ABSTRACT

We assessed knowledge gaps in foot-and-mouth disease (FMD) research. Findings are reported in a series of papers, and in this article, we consider biotherapeutics and disinfectants. The study took the form of a literature review (2011-2015) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD research. While vaccines will remain the key immunological intervention used against FMD virus (FMDV) for the foreseeable future, it takes a few days for the immune system to respond to vaccination. In an outbreak situation, protection could potentially be provided during this period by the application of rapid, short-acting biotherapeutics, aiming either to stimulate a non-specific antiviral state in the animal or to specifically inhibit a part of the viral life cycle. Certain antiviral cytokines have been shown to promote rapid protection against FMD; however, the effects of different immune-modulators appear to vary across species in ways and for reasons that are not yet understood. Major barriers to the effective incorporation of biotherapeutics into control strategies are cost, limited understanding of their effect on subsequent immune responses to vaccines and uncertainty about their potential impact if used for disease containment. Recent research has highlighted the importance of environmental contamination in FMDV transmission. Effective disinfectants for FMDV have long been available, but research is being conducted to further develop methods for quantitatively evaluating their performance under field, or near-field, conditions. During outbreaks in South Korea in 2010 there was public concern about potential environmental contamination after the mass use of disinfectant and mass burial of culled stock; this should be considered during outbreak contingency planning.


Subject(s)
Biological Therapy , Disinfectants , Foot-and-Mouth Disease/prevention & control , Animals
5.
Transbound Emerg Dis ; 63 Suppl 1: 30-41, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320164

ABSTRACT

This study assessed research knowledge gaps in the field of FMDV (foot-and-mouth disease virus) vaccines. The study took the form of a literature review (2011-15) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD vaccine research. Vaccines play a vital role in FMD control, used both to limit the spread of the virus during epidemics in FMD-free countries and as the mainstay of disease management in endemic regions, particularly where sanitary controls are difficult to apply. Improvements in the performance or cost-effectiveness of FMD vaccines will allow more widespread and efficient disease control. FMD vaccines have changed little in recent decades, typically produced by inactivation of whole virus, the quantity and stability of the intact viral capsids in the final preparation being key for immunogenicity. However, these are exciting times and several promising novel FMD vaccine candidates have recently been developed. This includes the first FMD vaccine licensed for manufacture and use in the USA; this adenovirus-vectored FMD vaccine causes in vivo expression of viral capsids in vaccinated animals. Another promising vaccine candidate comprises stabilized empty FMDV capsids produced in vitro in a baculovirus expression system. Recombinant technologies are also being developed to improve otherwise conventionally produced inactivated vaccines, for example, by creating a chimeric vaccine virus to increase capsid stability and by inserting sequences into the vaccine virus for desired antigen expression. Other important areas of ongoing research include enhanced adjuvants, vaccine quality control procedures and predicting vaccine protection from immune correlates, thus reducing dependency on animal challenge studies. Globally, the degree of independent vaccine evaluation is highly variable, and this is essential for vaccine quality. Previously neglected, the importance of evaluating vaccination programme effectiveness and impact is increasingly being recognized.


Subject(s)
Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/prevention & control , Viral Vaccines/immunology , Animals
6.
Transbound Emerg Dis ; 63 Suppl 1: 56-62, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320167

ABSTRACT

This study assessed gaps and priorities for FMDV (foot-and-mouth disease virus) research in the field of immunology. The study took the form of a literature review (2011-15) combined with research updates collected in 2014 from 33 institutes from across the world. Findings were used to identify priority areas for future FMD research. Improved understanding of FMDV immunology facilitates the development of vaccines, adjuvants and diagnostic tests, and will allow better assessment and prediction of vaccine potency and match, with reduced use of animals, particularly large animals, in experimental studies. Continued characterization of the immune systems of several FMD host species has underpinned substantial advances in knowledge of their interaction with FMDV. Recent studies have shed light on the mechanisms underlying formation of the bovine B- and T-cell response; there is also a greater understanding of the significance of non-neutralizing antibodies during FMDV infection and the interactions of antibody-bound virus with immune cells. This knowledge is directly relevant to vaccine development, as well as understanding protection and cross-protection. Despite ongoing research, significant knowledge gaps remain in the areas of neonatal and mucosal immunity. The impact of maternally derived antibody upon the neonate's ability to respond to FMD vaccination has received some attention, but few firm conclusions can be drawn at this stage, and little is known of the cellular response of young animals in general. The mucosal immune system of FMDV-susceptible species requires continued characterization, especially if the potential of mucosal vaccine-delivery systems is to be realized for FMD immunization.


Subject(s)
Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/immunology , Animals
7.
Transbound Emerg Dis ; 63 Suppl 1: 42-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320165

ABSTRACT

This study assessed knowledge gaps in foot-and-mouth disease (FMD) research in the field of diagnostics. The study took the form of a literature review (2011-15) combined with research updates collected in 2014 from 33 institutes from around the world. Findings were used to identify priority areas for future FMD research. Molecular and genetic technologies, including sequencing, are developing at an increasing rate both in terms of capability and affordability. These advances potentiate progress in many other fields of research, from vaccine development to epidemiology. The development of RT-LAMP represents an important breakthrough allowing greater use and access to molecular diagnostics. It is now possible to determine virus serotype using PCR, although only for certain virus pools, continued progress is needed to cover the global spectrum of FMD viruses. Progress has also been made in the development of pen-side rapid diagnostics, some with the ability to determine serotype. However, further advances in pen-side serotype or strain determination would benefit both FMD-free countries and endemic countries with limited access to well-resourced laboratories. Novel sampling methods that show promise include air sampling and baited ropes, the latter may aid sampling in wildlife and swine. Studies of infrared thermography for the early detection of FMD have not been encouraging, although investigations are ongoing. Multiplex tests have been developed that are able to simultaneously screen for multiple pathogens with similar clinical signs. Crucial for assessing FMDV freedom, tests exist to detect animals that have been infected with FMDV regardless of vaccination status; however, limitations exist, particularly when testing previously vaccinated animals. Novel vaccines are being developed with complementary DIVA tests for this purpose. Research is also needed to improve the current imprecise approaches to FMD vaccine matching. The development of simple, affordable tests increases access to FMD diagnostics, greatly benefiting regions with limited laboratory capacity.


Subject(s)
Foot-and-Mouth Disease/diagnosis , Animals
8.
Transbound Emerg Dis ; 63 Suppl 1: 63-71, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27320168

ABSTRACT

We assessed research knowledge gaps in the fields of FMDV (foot-and-mouth disease virus) pathogenesis and molecular biology by performing a literature review (2011-15) and collecting research updates (2014) from 33 institutes from across the world. Findings were used to identify priority areas for future research. There have been important advances in FMDV pathogenesis; FMDV remains in lymph nodes of many recovered animals that otherwise do not appear persistently infected, even in species previously not associated with the carrier state. Whether virus retention helps maintain host immunity and/or virus survival is not known. Studies of FMDV pathogenesis in wildlife have provided insights into disease epidemiology, in endemic and epidemic settings. Many aspects of FMDV infection and virus entry remain unknown; however, at the cellular level, we know that expression level and availability of integrins (that permit viral entry), rate of clearance of infected cells and strength of anti-viral type I IFN (interferon) response are key determinants of tissue tropism. Extending findings to improved understanding of transmission requires a standardized approach and adoption of natural routes of infection during experimental study. There has been recognition of the importance of autophagosomes for FMDV entry into the cytoplasm following cell surface receptor binding, and that distinct internal cellular membranes are exploited for viral replication and immune evasion. New roles for viral proteins in blocking type I IFN production and downstream signalling have been identified facilitating research in anti-viral therapeutics. We know more about how infection affects cell protein expression, and research into molecular determinants of capsid stability has aided the development of stable vaccines. We have an expanding knowledge of viral and host molecular determinates of virulence and infectiousness, and of how phylogenetics may be used to estimate vaccine match and strain distribution. With ongoing advances, these areas could translate into significantly improved disease control.


Subject(s)
Foot-and-Mouth Disease Virus/pathogenicity , Foot-and-Mouth Disease/virology , Animals
9.
J Virol ; 86(10): 5452-66, 2012 May.
Article in English | MEDLINE | ID: mdl-22419811

ABSTRACT

Dendritic cells (DC) are potent antigen-presenting cells and central to the induction of immune responses following infection or vaccination. The collection of DC migrating from peripheral tissues by cannulation of the afferent lymphatic vessels provides DC which can be used directly ex vivo without extensive in vitro manipulations. We have previously used bovine migrating DC to show that recombinant human adenovirus 5 vectors efficiently transduce afferent lymph migrating DEC-205(+) CD11c(+) CD8(-) DC (ALDC). We have also shown that recombinant modified vaccinia virus Ankara (MVA) infects ALDC in vitro, causing downregulation of costimulatory molecules, apoptosis, and cell death. We now show that in the bovine system, modified vaccinia virus Ankara-induced apoptosis in DC draining from the skin occurs soon after virus binding via the caspase 8 pathway and is not associated with viral gene expression. We also show that after virus entry, the caspase 9 pathway cascade is initiated. The magnitude of T cell responses to mycobacterial antigen 85A (Ag85A) expressed by recombinant MVA-infected ALDC is increased by blocking caspase-induced apoptosis. Apoptotic bodies generated by recombinant MVA (rMVA)-Ag85A-infected ALDC and containing Ag85A were phagocytosed by noninfected migrating ALDC expressing SIRPα via actin-dependent phagocytosis, and these ALDC in turn presented antigen. However, the addition of fresh ALDC to MVA-infected cultures did not improve on the magnitude of the T cell responses; in contrast, these noninfected DC showed downregulation of major histocompatibility complex class II (MHC-II), CD40, CD80, and CD86. We also observed that MVA-infected ALDC promoted migration of DEC-205(+) SIRPα(+) CD21(+) DC as well as CD4(+) and CD8(+) T cells independently of caspase activation. These in vitro studies show that induction of apoptosis in DC by MVA vectors is detrimental to the subsequent induction of T cell responses.


Subject(s)
Antigen Presentation , Apoptosis , Caspases/metabolism , Dendritic Cells/cytology , Tuberculosis/immunology , Vaccinia virus/immunology , Viral Vaccines/immunology , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Caspases/genetics , Caspases/immunology , Cattle , Dendritic Cells/immunology , Dendritic Cells/metabolism , Down-Regulation , Genetic Vectors/genetics , Genetic Vectors/immunology , Humans , Mycobacterium bovis/genetics , Mycobacterium bovis/immunology , Signal Transduction , Tuberculosis/enzymology , Tuberculosis/physiopathology , Tuberculosis/virology , Vaccinia virus/genetics , Vaccinia virus/physiology , Viral Vaccines/genetics
10.
Vaccine ; 30(13): 2357-67, 2012 Mar 16.
Article in English | MEDLINE | ID: mdl-22281103

ABSTRACT

Understanding how pathogens or vaccine antigens are targeted to dendritic cell (DC) subsets is important for disease pathogenesis studies and vaccine design. We characterised the sub-populations of migrating bovine DC with functional and phenotypic diversity present in pseudoafferent lymph draining the skin. These skin draining DC exist as a series of maturation dependent subsets with differential capacities for antigen uptake and cytokine expression, and include both Langerhans' cells (LC) and dermal derived cells. Furthermore, Mycobacterium bovis Bacille Calmette Guerin, a vaccine which is administered by the intradermal route, was only taken up by a small number of the migrating DC, which were SIRPα(+) and expressed the mannose receptor and CD1b. This was evident following in vitro infection and also in vivo following inoculation of green fluorescent BCG over the lymphatic cannulation site. Only the SIRPα(+) DC were able to present antigen to T cells isolated from BCG vaccinated calves. Furthermore, presentation of BCG antigens by DC to T lymphocytes was ineffective compared to mycobacterial proteins. However, mycobacterial antigen 85 was delivered more effectively to DC via an adenoviral vector and the magnitude of the subsequent antigen-specific T cell response was significantly increased. This study further extends our understanding of the biology of migrating DC, identifies potential explanations for the modest success of BCG vaccination and demonstrates that targeted delivery of antigens via adenoviruses to DC can improve antigen presentation.


Subject(s)
Antigen-Presenting Cells/immunology , BCG Vaccine/immunology , Cell Movement , Dendritic Cells/immunology , Lymph Nodes/immunology , Mycobacterium bovis/immunology , Adenoviridae/genetics , Adenoviridae/immunology , Animals , Antigen Presentation/immunology , Antigen-Presenting Cells/cytology , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Cattle , Cytokines/biosynthesis , Dendritic Cells/cytology , Dermis/immunology , Langerhans Cells/immunology , Lectins, C-Type/metabolism , Lymphocyte Activation , Mannose Receptor , Mannose-Binding Lectins/metabolism , Phenotype , Receptors, Cell Surface/metabolism , Receptors, Immunologic/metabolism , T-Lymphocytes/immunology
11.
Vet Immunol Immunopathol ; 148(1-2): 145-8, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-21616546

ABSTRACT

Foot-and-mouth disease virus, a highly contagious pathogen that can cause lameness, low weight and decreased milk production, is a scourge of agricultural livestock around the world. Although the acute phase of infection is rarely fatal, infection may persist in animals that have apparently recovered, creating a viral reservoir that some fear could contribute to the spread of disease. We have used an array of molecular techniques to search for traces of virus in tissues from the mouths and throats of infected cattle. In a carefully controlled study, we have found evidence of intact, non-replicating virus particles trapped by follicular dendritic cells within the germinal centres of lymph nodes. Strikingly, virus was present for up to 38 days post infection, even though it was undetectable in surrounding tissues. The retention of intact virus within germinal centres is likely to have a role in stimulating the long lasting immune response that is characteristic of viral infections. Our data suggests that this capture may also be responsible for preserving intact viruses capable of infecting susceptible cells as they come into contact with germinal centres. African buffalo (Syncerus caffer) are typically infected with all three South African Territories types of FMDV by 2 years of age and these viruses can be transmitted to farmed livestock. Buffalo harbour persistent virus in greater amounts and for longer periods than cattle and thus provided us with further opportunities to define the sites of viral localisation.


Subject(s)
Buffaloes/virology , Cattle Diseases/virology , Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/virology , Lymphoid Tissue/virology , Animals , Cattle , Cattle Diseases/immunology , Disease Reservoirs , Foot-and-Mouth Disease/immunology , Lymphoid Tissue/immunology
13.
J Virol ; 85(18): 9385-94, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21752909

ABSTRACT

Targeting dendritic cells (DC) is key to driving effective immune responses. Lymphatic cannulation provides access to the heterogeneous populations of DC draining peripheral sites in rodents and ruminants. Afferent lymph DEC-205(+) CD11c(+) SIRPα(+) DC were preferentially infected ex vivo with three vaccine viral vectors: recombinant human replication-defective human adenovirus 5 (rhuAdV5), recombinant modified vaccinia virus Ankara (rMVA), and recombinant fowlpox virus (rFPV), all expressing green fluorescent protein (GFP). The rhuAdV5-infected cells remained viable, and peak GFP expression was observed 16 to 24 h posttransduction. Increasing the incubation period of DC with rhuAdV5 enhanced GFP expression. In contrast, DC infected with rMVA-GFP or rFPV-GFP became rapidly apoptotic and GFP expression peaked at 6 h postinfection. Delivery of foot-and-mouth disease virus (FMDV) A(22) antigen to DC by rhuAdV5-FMDV-A(22) ex vivo resulted in significantly greater CD4(+) T cell proliferation than did delivery by rFPV-FMDV-A(22). Delivery of rhuAdV5-GFP in oil adjuvant in vivo, to enhance DC-vector contact, resulted in increased GFP expression in migrating DC compared to that with vector alone. Similarly, CD4(+) T cell responses were significantly enhanced when using rhuAdV5-FMDV-A(22) in adjuvant. Therefore, the interaction between viral vectors and afferent lymph DC ex vivo can predict the outcome of in vivo immunization and provide a means of rapidly assessing the effects of vector modification.


Subject(s)
Adenoviruses, Human/immunology , Dendritic Cells/immunology , Dendritic Cells/virology , Fowlpox virus/immunology , Vaccinia virus/immunology , Viral Vaccines/immunology , Adenoviruses, Human/genetics , Adenoviruses, Human/pathogenicity , Animals , Antigens, Viral/genetics , Antigens, Viral/immunology , CD4-Positive T-Lymphocytes/immunology , Cattle , Cell Proliferation , Cell Survival , Foot-and-Mouth Disease Virus/genetics , Foot-and-Mouth Disease Virus/immunology , Fowlpox virus/pathogenicity , Lymph Nodes/cytology , Lymph Nodes/immunology , Vaccination/methods , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunology , Vaccinia virus/pathogenicity , Viral Vaccines/administration & dosage , Viral Vaccines/genetics
14.
Transbound Emerg Dis ; 58(4): 283-90, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21501424

ABSTRACT

Foot-and-mouth disease virus causes a serious disease of livestock species, threatening free global trade and food security. The disease spreads rapidly between animals, and to ensure a window of opportunity for such spread, the virus has evolved multiple mechanisms to subvert the early immune response. The cycle of infection in the individual animal is very short, infection is initiated, disseminated throughout the body and infectious virus produced in <7 days. Foot-and-mouth disease virus has been shown to disrupt the innate response in vitro and also interacts directly with antigen-presenting cells and their precursors. This interaction results in suboptimal immune function, favouring viral replication and the delayed onset of specific adaptive T-cell responses. Detailed understanding of this cycle is crucial to effectively control disease in livestock populations. Knowledge-based vaccine design would specifically target and induce the immunological mechanisms of early protection and of robust memory induction. Specifically, information on the contribution of cytokines and interferon, innate immune cells as well as humoral and cellular immunity can be employed to design vaccines promoting such responses. Furthermore, understanding of viral escape mechanisms of immunity can be used to create attenuated viruses that could be used to develop novel vaccines and to study viral pathogenesis.


Subject(s)
Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease/virology , Immunity, Innate , Animals , Foot-and-Mouth Disease/immunology , Host-Pathogen Interactions/immunology
15.
J Virol ; 85(5): 2212-23, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21177807

ABSTRACT

Foot-and-mouth disease virus (FMDV) causes an acute vesicular disease of farm animals. The development of successful control strategies is limited by an incomplete understanding of the immune response to FMDV. Dendritic cells (DC) mediate the induction of immunity to pathogens, but their role in FMDV infection of cattle is uncharacterized. Bovine monocyte-derived DC (moDC) were exposed to integrin-binding and cell culture-adapted strains of FMDV in vitro. MoDC were not largely susceptible to infection by integrin-binding FMDV but were susceptible to culture-adapted virus. Binding specific antibodies to integrin-binding FMDV at neutralizing or subneutralizing IgG concentrations significantly enhanced infection via CD32 (FcγR). Monocytes also expressed CD32 but were nonsusceptible to FMDV immune complex (IC) infection, indicating a requirement for additional factors involved in cellular susceptibility. Infection of moDC by the FMDV IC was productive and associated with high levels of cell death. Infected moDC were unable to efficiently stimulate FMDV-specific CD4(+) memory T cells, but exposing moDC to IC containing inactivated FMDV resulted in significantly increased T cell stimulation. Thus, neutralized FMDV concurrently loses its ability to infect susceptible cells while gaining the capacity to infect immune cells. This represents a change in the tropism of FMDV that could occur after the onset of the antibody response. We propose that IC could dynamically influence the anti-FMDV immune response and that this may explain why the early immune response to FMDV has evolved toward T cell independence in vivo. Moreover, we propose that DC targeting could prove useful in the development of effective vaccines against FMDV.


Subject(s)
Antibodies, Viral/immunology , Cattle Diseases/immunology , Dendritic Cells/cytology , Foot-and-Mouth Disease Virus/physiology , Foot-and-Mouth Disease/immunology , Immunoglobulins/immunology , Viral Tropism , Animals , Cattle , Cattle Diseases/physiopathology , Cattle Diseases/virology , Cell Death , Cell Line , Cells, Cultured , Cricetinae , Dendritic Cells/immunology , Dendritic Cells/virology , Female , Foot-and-Mouth Disease/physiopathology , Foot-and-Mouth Disease/virology , Foot-and-Mouth Disease Virus/immunology , Integrins/immunology , Male , Receptors, IgG/immunology
16.
J Gen Virol ; 91(Pt 4): 1038-46, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20007358

ABSTRACT

Classical swine fever virus (CSFV) causes severe disease in pigs associated with leukopenia, haemorrhage and fever. We show that CSFV infection protects endothelial cells from apoptosis induced by the dsRNA mimic, pIpC, but not from other apoptotic stimuli, FasL or staurosporine. CSFV infection inhibits pIpC-induced caspase activation, mitochondrial membrane potential loss and cytochrome c release as well as the pro-apoptotic effects of truncated Bid (tBid) overexpression. The CSFV proteins N(pro) and E(rns) both contribute to CSFV inhibition of apoptosis. We conclude that CSFV infection can inhibit apoptotic signalling at multiple levels, including at the caspase-8 and the mitochondrial checkpoints. By supporting viral replication, endothelial cells may promote CSFV pathogenesis.


Subject(s)
Apoptosis/drug effects , Classical Swine Fever Virus/pathogenicity , Endothelial Cells/physiology , RNA, Double-Stranded/pharmacology , Animals , Aorta/drug effects , Aorta/pathology , Aorta/virology , BH3 Interacting Domain Death Agonist Protein/physiology , Caspases/metabolism , Cells, Cultured , Cytochromes c/metabolism , Endothelial Cells/drug effects , Endothelial Cells/virology , Enzyme Activation , Swine , Viral Envelope Proteins/physiology
17.
Vet Rec ; 163(5): 139-47, 2008 Aug 02.
Article in English | MEDLINE | ID: mdl-18676997

ABSTRACT

A case of foot-and-mouth disease (fmd) on a cattle farm in Normandy, Surrey, was confirmed on Friday August 3, 2007, the first case in the uk since 2001. The infection was detected nearby on a second farm on August 6. On September 12, fmd was confirmed on a farm approximately 20 km from Normandy in Egham, and this was followed by cases on five more farms in that area in the next three weeks. The majority of the infected farms consisted of multiple beef cattle holdings in semi-urban areas. In total, 1578 animals were culled on the infected farms, and fmd virus infection was confirmed in 278 of them by the detection of viral antigen, genome or antibodies to the virus, or by clinical signs. This paper describes the findings from animal inspections on the infected farms, including the estimated ages of the fmd lesions and the numbers of animals infected. It also summarises the test results from samples taken for investigation, including the detection of preclinically viraemic animals by using real-time reverse transcriptase-pcr.


Subject(s)
Cattle Diseases/epidemiology , Disease Outbreaks/veterinary , Foot-and-Mouth Disease/epidemiology , Sheep Diseases/epidemiology , Swine Diseases/epidemiology , Animals , Antibodies, Viral/blood , Antigens, Viral/blood , Cattle , Cattle Diseases/blood , Cattle Diseases/virology , England/epidemiology , Female , Foot-and-Mouth Disease/blood , Foot-and-Mouth Disease/virology , Foot-and-Mouth Disease Virus/immunology , Foot-and-Mouth Disease Virus/isolation & purification , Male , Reverse Transcriptase Polymerase Chain Reaction/veterinary , Sheep , Sheep Diseases/blood , Sheep Diseases/virology , Swine , Swine Diseases/blood , Swine Diseases/virology
18.
Int J Parasitol ; 38(14): 1693-704, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18590735

ABSTRACT

Theileria parva causes an acute lympho-proliferative disease in cattle, which can result in death of susceptible animals within 2-3 weeks of infection. Analyses of the cellular response in the lymph node draining the site of infection demonstrated an early T cell response, with the appearance of large numbers of uninfected lymphoblasts between 6 and 9 days p.i., coinciding with initial detection of parasitised cells. There was a marked increase in the representation of CD8(+) T cells and the emergence of a sizable sub-population of CD2(-) CD8(+) alpha/beta T cells during this period. Analysis of T cell receptor beta chain variable (TCR BV) gene expression did not reveal any evidence for the involvement of a superantigen in stimulating the response. Responding lymph node cells were found to produce increased quantities of IFNgamma and IL-10, and both the CD2(+) CD8(+) and CD2(-) CD8(+) populations expressed IFNgamma transcripts. Purified CD2(+) CD8(+) cells proliferated when stimulated in vitro with autologous parasitised cells or non-specific mitogens, whereas CD2(-) CD8(+) cells were refractory to these stimuli. In contrast to the parasite-specific cytotoxic activity associated with T cell responses in immune cattle, the responses to primary infection exhibited variable levels of non-specific cytotoxic activity. Stimulation of purified CD2(+) CD8(+) T cells in vitro with autologous parasitised cells also failed to reveal evidence of specific cytotoxic activity. These findings indicate that primary infection with T. parva induces an aberrant T cell response that lacks appropriate effector activity.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Theileria parva/immunology , Theileriasis/immunology , Animals , CD8-Positive T-Lymphocytes/parasitology , Cattle , Cell Proliferation , Cytotoxicity, Immunologic , Interferons/metabolism , Interleukin-10/metabolism , Lymph/immunology , Lymph/parasitology , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/parasitology , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Theileriasis/pathology
19.
J R Soc Interface ; 4(14): 545-51, 2007 Jun 22.
Article in English | MEDLINE | ID: mdl-17251130

ABSTRACT

Concurrent infection of cattle with bovine viral diarrhoea virus (BVDV) and Mycobacterium bovis is considered to be a possible risk factor for onward transmission of bovine tuberculosis (BTB) in infected cattle and is known to compromise diagnostic tests. A comparison is made here of M. bovis shedding (i.e. release) characteristics from 12 calves, six experimentally co-infected with BVDV and six infected with M. bovis alone, using simple models of bacterial replication. These statistical and mathematical models account for the intermittent or episodic nature of shedding, the dynamics of within-host bacterial proliferation and the sampling distribution from a given shedding episode. We show that while there are distinct differences among the shedding patterns of calves given the same infecting dose, there is no statistically significant difference between the two groups of calves. Such differences as there are, can be explained solely in terms of the shedding frequency, but with all calves potentially excreting the same amount of bacteria in a given shedding episode post-infection. The model can be thought of as a process of the bacteria becoming established in a number of discrete foci of colonization, rather than as a more generalized infection of the respiratory tract. In this case, the variability in the shedding patterns of the infected calves can be explained solely by differences in the number of foci established and shedding being from individual foci over time. Should maximum exposure on a particular occasion be a critical consideration for cattle-to-cattle transmission of BTB, cattle that shed only intermittently may still make an important contribution to the spread and persistence of the disease.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/complications , Models, Biological , Mycobacterium bovis/isolation & purification , Tuberculosis, Bovine/complications , Tuberculosis, Bovine/microbiology , Animals , Cattle , Colony Count, Microbial , Linear Models , Tuberculosis, Bovine/transmission
20.
Vaccine ; 24(47-48): 6850-8, 2006 Nov 17.
Article in English | MEDLINE | ID: mdl-17050044

ABSTRACT

Mycobacterium bovis is the causative agent of bovine tuberculosis (TB) and of a proportion of human TB. Protection against TB requires Th1 responses and worsening of disease is associated with Th2 responses. To help clarify the nature of the response to mycobacteria, the responses from M. bovis-BCG vaccinated cattle boosted with live mycobacteria (BCG), bacterial soluble antigens (PPD) or PBS were evaluated. The results indicated that macrophages may be the major cell population ingesting and presenting mycobacteria in BCG boosted animals, while B-cells seem able to ingest and present PPD to T-cells in PPD boosted animals.


Subject(s)
Adjuvants, Immunologic/pharmacology , Antigens, Bacterial/immunology , BCG Vaccine/immunology , Mycobacterium bovis/immunology , Animals , Antibodies, Bacterial/analysis , Antibodies, Bacterial/biosynthesis , Cattle , Cytokines/biosynthesis , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique , Genes, MHC Class II/immunology , Hypersensitivity, Delayed/immunology , Immunity, Cellular/immunology , Immunization, Secondary , Immunoglobulin G/analysis , Immunoglobulin G/biosynthesis , Interferon-gamma/biosynthesis , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymph Nodes/metabolism , Macrophages/immunology , Male , RNA, Messenger/biosynthesis , Skin Tests , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...